Literature - Publication Review

Inhibiting interleukin 11 signaling reduces and reverses many dangerous effects of NAFLD/NASH in mouse models

inhibiting-interleukin512

Accumulation of fat in liver cells, a process called steatosis, is a common health problem that has many possible causes. Nonalcoholic fatty liver disease (NAFLD) is a group of conditions caused by the buildup of fat in the liver, with some sources estimating that one in four people develop it in their lifetime. NAFLD, if left untreated, may progress to nonalcoholic steatohepatitis (NASH). Dr. Anissa A. Widjaja and colleagues recently examined the connection between interleukin 11 (IL-11) signaling and the development of liver disease. Read more about her study.

For research use only. Not for use in diagnostic procedures.

To view the full content please answer a few questions

By submitting my personal data, I acknowledge that Revvity Inc. and its affiliates (“Company”) will process my personal data provided above consistent with the Company’s Privacy Policy available here.

CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Download Resource

Inhibiting interleukin 11 signaling reduces and reverses many dangerous effects of NAFLD/NASH in mouse models

Download Literature - Publication Review